Emerging Considerations in the Management of PH-ILD

Emerging Considerations in the Management of PH-ILD is organized by Practice Point Communications (PPC).

Launch Date: March 10, 2021
Release Date: March 10, 2021
Expiration Date: February 28, 2022

Description:
Clinical Viewpoints PH-ILD includes a curriculum that highlights the very latest clinical data in pulmonary hypertension due to interstitial lung disease. Slides are developed and updated throughout the year by leading pulmonology expert physicians. Continue to visit the Lecture Library series throughout 2021 to view updates from new publications and conference updates. All content is reviewed and approved by the Clinical Viewpoints PH-ILD Planning Committee.

This activity is designed to provide an overview of the diagnosis, treatment, and management of patients presenting with PH-ILD. Latest evidence from completed and ongoing clinical trials will be presented to identify therapeutic approaches useful in reducing the symptom burden of afflicted patients. Current treatment paradigms, their limitations, and new developments in PH-ILD will also be discussed.

Additional details will be posted as soon as information is available.